Delivery Order SPE2DB22D3016-SPE2DB26FAAS1
Award Date 10/27/25
Potential Completion Date 11/18/25
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a contract ceiling value of $4,027.70. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 30, 2025, with fulfillment occurring at the vendor's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract. The award was issued on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) under a firm fixed-price contract valued at $7,352.24. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-set-aside competitive award. Performance of this contract will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price arrangement. The contract ceiling value is $12,083.10, with an ultimate completion date of October 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a total value of...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 80 mg on May 12, 2025, with completion expected by June 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. Ingrezza is a prescription medication used to treat involuntary movement disorders, reflecting the DLA's ongoing need to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units). This is a firm fixed-price, non-competitive delivery order with a completion date of September 11, 2025, and an award date of August 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform this work at its corporate office location. Ingrezza is a prescription...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,083.10 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. This non-competitive delivery order does not utilize a set-aside designation and represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. Performance will be...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ingrezza 60 mg capsules (30-count units) with a ceiling value of $4,049.61. The contract was competitively awarded without a set-aside designation and operates under a firm fixed price structure, with an ultimate completion date of November 14, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $8,077.31 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by October 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count) valued at $12,083.10 under a firm fixed-price contract type. The award was issued on September 18, 2025, with an ultimate completion date of October 9, 2025, and represents a non-competitive delivery order under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at...